D. E. Shaw & Co., Inc. Amgen Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Amgen Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 625,081 shares of AMGN stock, worth $210 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

625,081

Previous 1,260,884 50.43%

Holding current value

$210 Million

Previous $393 Million 55.57%

% of portfolio

0.14%

Previous 0.39%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$262.28 - $309.85 $167 Million - $197 Million	-635,803 Reduced 50.43%	625,081 $175 Million
Q1 2025 May 15, 2025	SELL	$258.59 - $327.36 $184 Million - $234 Million	-713,329 Reduced 36.13%	1,260,884 $393 Million
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $468 Million - $594 Million	1,807,767 Added 1086.1%	1,974,213 $515 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $43.4 Million - $47.3 Million	-140,234 Reduced 45.73%	166,446 $53.6 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $28.1 Million - $34.2 Million	-107,056 Reduced 25.88%	306,680 $95.8 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $38.2 Million - $46.1 Million	-142,016 Reduced 25.55%	413,736 $118 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $66.7 Million - $75.2 Million	-260,814 Reduced 31.94%	555,752 $160 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $7.87 Million - $9.77 Million	36,003 Added 4.61%	816,566 $219 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $99.1 Million - $117 Million	462,329 Added 145.28%	780,563 $173 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $210 Million - $256 Million	-931,891 Reduced 74.54%	318,234 $76.9 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $102 Million - $130 Million	447,032 Added 55.66%	1,250,125 $328 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $37.7 Million - $42.5 Million	-168,018 Reduced 17.3%	803,093 $181 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $9.23 Million - $10.3 Million	40,015 Added 4.3%	971,111 $236 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $119 Million - $132 Million	-543,418 Reduced 36.85%	931,096 $225 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $43.4 Million - $49.7 Million	218,444 Added 17.39%	1,474,514 $332 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $23.3 Million - $27.3 Million	109,648 Added 9.56%	1,256,070 $267 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $72 Million - $79.9 Million	308,427 Added 36.81%	1,146,422 $279 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $148 Million - $172 Million	665,063 Added 384.58%	837,995 $209 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $16.5 Million - $19.7 Million	76,361 Added 79.07%	172,932 $39.8 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $29.1 Million - $32.4 Million	-124,129 Reduced 56.24%	96,571 $24.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $141 Million - $173 Million	-711,280 Reduced 76.32%	220,700 $52.1 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $122 Million - $162 Million	669,822 Added 255.5%	931,980 $189 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $186 Million - $239 Million	-980,762 Reduced 78.91%	262,158 $63.2 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $13.8 Million - $16.6 Million	-79,411 Reduced 6.01%	1,242,920 $241 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $49.7 Million - $58.3 Million	-298,165 Reduced 18.4%	1,322,331 $244 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $200 Million - $226 Million	1,107,989 Added 216.19%	1,620,496 $308 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $837,766 - $977,942	4,696 Added 0.92%	512,507 $99.8 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $15 Million - $16.9 Million	-80,756 Reduced 13.72%	507,811 $105 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $35.2 Million - $39.6 Million	-212,219 Reduced 26.5%	588,567 $109 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $282 Million - $330 Million	-1,664,954 Reduced 67.52%	800,786 $137 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $139 Million - $155 Million	823,332 Added 50.13%	2,465,740 $429 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $275 Million - $314 Million	1,642,408	1,642,408 $306 Million

Others Institutions Holding AMGN

# of Institutions

3,268

Shares Held

430M

Call Options Held

6.52M

Put Options Held

6.84M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account